Start-Up Previews
Executive Summary
This Month's Profile Groups: Upheaval and Opportunity Reshape The Oncology Market features profiles of Cyterix Pharmaceuticals, Polaris, Tocagen, Tragara Pharmaceuticals and VentiRx Pharmaceuticals. Patient-Centric Devices Promise Cost-Efficient Wound Care features profiles of Reapplix, Spiracur and Wound Solutions. Plus these Start-Ups Across Health Care: Cebix, Jan Medical, Life Recovery Systems, Respira and SeptRx.
You may also be interested in...
Jan Medical Inc.
Just as nuclear submarines employ pressure waves to track objects in the sea, the Nautilus NeuroWave from Jan Medical Inc. uses the same technology to detect expansions and contractions of the skull caused by an increase or decrease in the amount of blood in the vascular system within the skull. These pressure waves will be used to quickly determine the type, location and size of stroke that a patient is experiencing.
Spiracur Inc.
Indicated for many types of acute and chronic wounds, negative pressure wound therapy kicks off many mechanisms useful in wound healing. However, the devices aren't used in all patients for whom they're indicated for reasons that have to do with inconvenience, logistics and quality of life. Spiracur offers the same negative pressure therapy in a small, entirely mechanical, tether-free disposable device that replaces the cumbersome electric pumps that dominate the market today.
Reapplix APS
When the healing process for chronic wounds like diabetic foot ulcers stalls, something must be done to prevent infection and amputation. Out of Denmark, Reapplix APS has a bedside device for creating a three-layered biological patch out of a patient's own blood, without additives, and within 20 minutes.